AOD-9604 is a synthetic peptide fragment of human growth hormone (Hgh 177-191, consisting of 37 amino acid residues) that has undergone chemical modification to enhance stability and bioavailability. It was originall...
AOD-9604 is a synthetic peptide fragment of human growth hormone (Hgh 177-191, consisting of 37 amino acid residues) that has undergone chemical modification to enhance stability and bioavailability. It was originally created as a pharmacological tool for combating excess weight and normalizing metabolic processes. Since the substance does not possess hormonal activity, it is integrated into body mass management protocols, sports recovery programs, and fitness courses. The injectable form is most effective at the initial stage of therapy, during intensive lipolysis cycles and peak physical exertion.
AOD-9604 reproduces the fat-burning properties of growth hormone while excluding undesirable metabolic reactions such as hyperglycemia and decreased tissue sensitivity to insulin. The compound activates the process of adipocyte breakdown (lipolysis) and suppresses the formation of new lipid reserves (lipogenesis). As a result, a reduction in fatty tissue volume and optimization of metabolism are observed.
|
Combination |
AOD + Synergist Dosages |
Result |
Duration |
|---|---|---|---|
|
+ CJC/Ipa |
300 mcg + 200/100 mcg |
GH increase + minus 15% fat |
8 weeks |
|
+ Tesamorelin |
400 mcg + 1-2 mg |
20% visceral fat reduction, recomposition |
12 weeks |
|
+ IGF-1 LR3 |
300 mcg + 50 mcg |
Muscle gain +4 kg / fat loss -10% |
6 weeks |
|
"Wolverine" |
300 mcg + CJC/Ipa + TB/BPC |
Mass gain, regeneration, cutting |
8 weeks |
The main area of use is weight correction and general health improvement of the body. The drug is relevant for individuals with diagnosed obesity or excessive body mass index, as well as for athletes seeking to improve their physical shape and quality of life.
|
Regimen |
Daily Dose |
Frequency |
Duration |
|---|---|---|---|
|
Basic |
300-500 mcg |
1 time (morning) |
8-12 weeks |
|
Enhanced |
500-750 mcg |
1-2 times |
4-6 weeks |
|
Targeted |
250 mcg |
Into problem area |
6 weeks |
The drug is recommended for those who require rapid subcutaneous fat elimination, improved quality of metabolic response, and increased productivity of the training process. This scheme contributes to more efficient calorie expenditure, improves the body's adaptive capabilities to stress, and accelerates the achievement of set aesthetic and athletic goals.
Despite a high safety profile, some users may experience negative manifestations: cephalgia, dyspepsia, vertigo, and individual intolerance. Before implementing any similar agents, it is necessary to obtain medical consultation and strictly adhere to the specialist's prescriptions.
